Similarly, a set of 11 potential therapeutic targets (AKT1, CCND1, CASP3, CTNNB1, EGF, EGFR, MYC, MAPK3, STAT3, TNF, TP53) was directly related to the KEGG pathway “hepatitis C” and interconnected with 23 compounds (SQ7, ZJ11, ZJ3, ZJ4, CBM9, CF2, CF3, QYS8, ZJ8, CL3, CL5, ZJ6, DSL4, DSL5, JTS1, TM12, XYS18, CL2, ZJ10, ZJ12, ZJ2, DSL6, ZZS1; Table S2). The gene discussed is CCND1; the disease is hepatitis C virus infection.